FDA Import Refusal 9UA-0287614-4/61/1C — BALAXI HEALTHCARE DOMINICANA
The FDA refused shipment 9UA-0287614-4/61/1C from BALAXI HEALTHCARE DOMINICANA (Dominican Republic) on Mar 27, 2023. The refused product falls under Drugs and Biologics — ACETAMINOPHEN (ANALGESIC). Cited charges: 118,75 This firm has 2 other import refusals on record.
Refusal details
- Date
- Mar 27, 2023
- Country
- Dominican Republic
- Product Category
- Drugs and Biologics
- Product Code
- 60LAY01 ACETAMINOPHEN (ANALGESIC)
- Charges
- 118,75